XML 37 R18.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 12 - Share-based Compensation
12 Months Ended
Jun. 30, 2016
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
(1
2
)
Share-Based Compensation
 
For the fiscal years ended June 30, 2016, 2015 and 2014, the Company recorded share-based compensation expense related to grants from equity incentive plans of $2.0 million, $2.1 million, and $1.7 million, respectively. No income tax benefit was recognized in the statements of operations and no share-based compensation expense was capitalized as part of any assets for the fiscal years ended June 30, 2016 and 2015.
 
Stock Options
.
The fair value of each stock option award was estimated at its respective date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions:
 
 
 
 
Fiscal Years
Ended
June 30,
 
                         
 
 
201
6
 
 
201
5
 
 
2014
 
Risk-free interest rate
    1.40
%
    1.70
%
    1.50
%
Dividend yield
                 
Expected volatility
    .75       .82       .79  
Expected life of options (years)
    4.8       5.9       5.9  
Fair value of options granted
  $ 1.26     $ 1.65     $ 2.47  
 
The risk-free rate interest rate is based on the expected life of the option and the corresponding U.S. Treasury bond, which in most cases is the U.S. five year Treasury bond. The expected term of stock options granted is derived from actual and expected option behavior and represents the period of time that options granted are expected to be outstanding. The Company uses historical data to estimate option exercise patterns and future employee terminations to determine expected life and forfeitures. Expected volatility is based on the historical volatility of the Company’s publicly traded common stock. The following table summarizes the stock option activity for the fiscal years end June 30, 2016 and 2015:
 
 
 
 
 
 
 
Weighted Average
 
 
Weighted-Average
 
 
Aggregate Intrinsic
 
 
 
Number of
 
 
Exercise Price
 
 
Remaining Contractual
 
 
Value
 
 
 
Stock Options
 
 
Per Option
 
 
Term
 
 
 
$(0000)
 
                                 
Balance at June 30, 2014
    2,463,369     $ 9.09                  
Granted
    1,432,000       2.42                  
Exercised
                           
Forfeited or expired
    (531,252 )     13.37                  
Balance at June 30, 2015
    3,364,117       5.58       7.9     $ -  
Granted
    1,636,667       2.17                  
Exercised
                           
Forfeited or expired
    (249,361 )     12.77                  
Balance at June 30, 2016
    4,751,423     $ 4.07       6.6     $ -  
 
The total intrinsic value of stock options exercised during the fiscal years ended June 30, 2016 and 2015 was zero, and no cash proceeds were received by the Company. Further, no actual tax benefits were realized, as the Company currently records a full valuation allowance for all tax benefits due to uncertainties with respect to its ability to generate sufficient taxable income in the future.
 
The following tables summarize information relating to outstanding and exercisable stock options as of June 30, 2016:
 
 
 
 
 
 
June 30, 201
6
 
 
 
 
 
 
Outstanding
 
 
Exercisable
 
 
 
 
 
 
 
 
 
 
Weighted Average
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Number of
 
 
Remaining
 
 
Weighted Average
 
 
Number of
 
 
Weighted Average
 
Exercise Prices
 
 
Shares
 
 
Contractual Life
 
 
Exercise Price
 
 
Shares
 
 
Exercise Price
 
 
 
 
 
 
 
 
 
 
(In Years)
 
 
 
 
 
 
 
 
 
 
 
 
 
                                               
$1.37 $2.40       1,948,647       8.03     $ 2.17       465,007     $ 2.38  
$2.47 $2.85       1,257,500       5.63       2.56       201,250       2.75  
$3.14 $4.24       1,299,090       6.04       4.07       1,196,590       4.06  
$6.11 $39.60       246,186       3.76       26.81       216,186       29.64  
            4,751,423       6.63     $ 4.07       2,079,033     $ 6.22  
 
 
Restricted Stock Awards.
A summary of the Company’s outstanding restricted stock activity for the fiscal years ended June 30, 2016 and 2015 is as follows:
 
 
 
 
 
 
 
Weighted-Average
 
 
 
 
 
 
 
Grant Date
 
 
 
Shares
 
 
Fair Value
 
                 
Outstanding at June 30, 2014
    8,750     $ 3.93  
Granted
           
Forfeited
           
Outstanding at June 30, 2015
    8,750       3.93  
Granted
           
Forfeited
           
Outstanding at June 30, 2016
    8,750     $ 3.93  
 
 
Restricted Stock Units and Market Stock Units (MSUs).
A summary of the Company’s outstanding restricted stock and market stock unit (MSU) activity for the fiscal years ended June 30, 2016 and 2015 is as follows:
 
 
 
Shares
 
 
Weighted
Average
Grant Date
Fair Value
 
Outstanding at June 30, 2014
    189,427     $ 3.94  
Awarded
    47,500       2.41  
Released
    (80,144 )     3.94  
Forfeited
    (60,202 )     3.87  
Unvested at June 30, 2015
    96,581       3.23  
Awarded
    2,500       2.49  
Released
    (43,541 )     2.44  
Forfeited
    (6,334 )     2.41  
Outstanding at June 30, 2016
    49,206     $ 4.00  
 
In December 2013, the Company awarded 108,133 MSUs to employees that can vest on January 1, 2017. The vesting of these awards is subject to the respective employee’s continued employment through this settlement period. The number of MSUs granted represents the target number of units that are eligible to be earned based on the attainment of certain market-based criteria involving the Company’s stock price. The number of MSUs actually earned is calculated upon the vesting of the award. Participants may ultimately earn between 0% and 250% of the target number of units granted based on actual stock performance. Accordingly, additional MSUs may be issued or currently outstanding MSUs may be cancelled upon final determination of the number of awards earned. Compensation expense, including the effect of forfeitures, is recognized over the applicable service period.
 
The Company values grants of MSUs using a lattice model with a Monte Carlo simulation. This valuation methodology utilizes several key assumptions, including the 20-day average closing stock price on the grant date, expected volatility of the Company’s stock price, risk-free rates of return and expected dividend yield. There were no grants of MSUs for the fiscal years ended June 30, 2016 and June 30, 2015. The assumptions used in the Company’s valuation of the MSU’s are summarized as follows:
 
 
 
For the
Fiscal
Year
Ended
June
3
0
,
 
 
 
201
4
 
Expected dividend yield
    0.00 %
Expected stock price volatility
    0.86  
Risk-free interest rate
    0.64 %
20-day trading average stock price on grant date
  $ 3.98  
Weighted-average per share grant date fair value
  $ 7.69  
 
As of June 30, 2016 and 2015 there was $2.6 million and $3.2 million, respectively, of unrecognized share-based compensation expense related to all unvested share-based awards, discounted for future forfeitures. This balance is expected to be recognized over a weighted-average period of two years.